The use of biosimilar or originator follitropin alfa preparations in progestin primed ovarian stimulation protocols (ppos) result in similar clinical outcomes

Fertility and Sterility(2022)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要